HSCS
Heart Test Laboratories Inc. Common Stock
NASDAQ: HSCS · HEALTHCARE · MEDICAL DEVICES
$1.98
-1.00% today
Updated 2026-04-29
Market cap
$6.40M
P/E ratio
—
P/S ratio
738.41x
EPS (TTM)
$-4.49
Dividend yield
—
52W range
$2 – $6
Volume
0.0M
Heart Test Laboratories Inc. Common Stock (HSCS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-3.84M | $-2.45M | $-3.64M | $-5.77M | $-6.07M | $-7.41M |
| Capital expenditures | $11424.00 | $712.00 | $1932.00 | $18308.00 | $125271.00 | $30188.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $135067.00 | $24675.00 | $68396.00 | $248308.00 | $405025.00 | $249884.00 |
| Free cash flow | $-3.85M | $-2.45M | $-3.65M | $-5.79M | $-6.20M | $-7.44M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |